載入...
Current advances in biomarkers for targeted therapy in triple-negative breast cancer
Triple-negative breast cancer (TNBC) is a complex heterogeneous disease characterized by the absence of three hallmark receptors: human epidermal growth factor receptor 2, estrogen receptor, and progesterone receptor. Compared to other breast cancer subtypes, TNBC is more aggressive, has a higher pr...
Na minha lista:
| 發表在: | Breast Cancer (Dove Med Press) |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5063595/ https://ncbi.nlm.nih.gov/pubmed/27785100 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S114659 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|